Biomoda is committed to the vision that the early detection of cancer is achievable in our lifetime. Through the developments of our technologies and an array of complimentary business models, Biomoda is creating diagnostic tools to assist clinicians in early detection, staged diagnosis and aid in determining therapy routes. Biomoda's prototype tests are inexpensive, simple and accurate. Our business plan is to focus on economically large markets where our proprietary, patented technology will significantly reduce overall costs in the healthcare system and improve patient outcomes. At Biomoda, our mission is to create and market new diagnostic solutions for the early detection and clinical management of cancer; solutions that provide compelling value to the healthcare system through cost savings and improved patient outcomes.